Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. July 30, 2018. Erik Paulsen.

Executive Summary

Arguing that permanently ending the 2.3% medical device tax would restore jobs at medtech companies and provide more predictability for industry, US Rep. Erik Paulsen and other GOP House members opposed to the tax voted to abolish it. See what Paulsen said about it here.

"Medical device firms already face challenges when they bring their products to FDA for approval, and then must undergo review at CMS [Centers for Medicare and Medicaid Services] to get Medicare reimbursement. This bill is about giving more predictably, and certainty to an industry which makes lifesaving machines and medical supplies." –Erik Paulsen, member (R-Minn.), US House of Representatives

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel